Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis

NCT00037102 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: interferon beta 1a
DRUG: methotrexate

Sponsor

MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute

Collaborators

[object Object]
[object Object]